Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Gatzemeier

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Phase ii comparator study of oral versus intravenous topotecan in patients with chemosensitive small-cell lung cancerJ von Pawel, U Gatzemeier, J L Pujol, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2000
Phase III comparative study of high-dose cisplatin versus a combination of paclitaxel and cisplatin in patients with advanced non-small-cell lung cancerU Gatzemeier, J von Pawel, M Gottfried, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2000
Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancerA B Sandler, J Nemunaitis, C Denham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Effects of granulocyte-macrophage colony-stimulating factor and dose intensification of V-ICE chemotherapy in small-cell lung cancer: a prospective randomized study of 300 patientsW P Steward, J von Pawel, U Gatzemeier, et al.
European Journal of Cancer (Oxford, England : 1990)|February 1, 1996
Activity of gemcitabine in patients with non-small cell lung cancer: a multicentre, extended phase II studyU Gatzemeier, F A Shepherd, T Le Chevalier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2002
Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trialR Rosell, U Gatzemeier, D C Betticher, et al.
Bulletin Du Cancer|March 1, 1997
[A phase II multicenter study of gemcitabine in non small cell lung cancers]T Le Chevalier, M Gottfried, U Gatzemeier, et al.
Lung Cancer (Amsterdam, Netherlands)|April 14, 2012
Prognostic factors in patients with advanced non-small cell lung cancer: data from the phase III FLEX studyR Pirker, J R Pereira, A Szczesna, et al.
Lung Cancer (Amsterdam, Netherlands)|July 19, 2005
Randomized study of vinorelbine--gemcitabine versus vinorelbine--carboplatin in patients with advanced non-small cell lung cancerE H Tan, A Szczesna, M Krzakowski, et al.
Lung Cancer (Amsterdam, Netherlands)|March 1, 2003
Ifosfamide, carboplatin and etoposide combined with 41.8 degrees C whole body hyperthermia for malignant pleural mesotheliomaA Bakhshandeh, I Bruns, A Traynor, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Phase ii comparator study of oral versus intravenous topotecan in patients with chemosensitive small-cell lung cancerJ von Pawel, U Gatzemeier, J L Pujol, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2000
Phase III comparative study of high-dose cisplatin versus a combination of paclitaxel and cisplatin in patients with advanced non-small-cell lung cancerU Gatzemeier, J von Pawel, M Gottfried, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2000
Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancerA B Sandler, J Nemunaitis, C Denham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Effects of granulocyte-macrophage colony-stimulating factor and dose intensification of V-ICE chemotherapy in small-cell lung cancer: a prospective randomized study of 300 patientsW P Steward, J von Pawel, U Gatzemeier, et al.
European Journal of Cancer (Oxford, England : 1990)|February 1, 1996
Activity of gemcitabine in patients with non-small cell lung cancer: a multicentre, extended phase II studyU Gatzemeier, F A Shepherd, T Le Chevalier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2002
Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trialR Rosell, U Gatzemeier, D C Betticher, et al.
Bulletin Du Cancer|March 1, 1997
[A phase II multicenter study of gemcitabine in non small cell lung cancers]T Le Chevalier, M Gottfried, U Gatzemeier, et al.
Lung Cancer (Amsterdam, Netherlands)|April 14, 2012
Prognostic factors in patients with advanced non-small cell lung cancer: data from the phase III FLEX studyR Pirker, J R Pereira, A Szczesna, et al.
Lung Cancer (Amsterdam, Netherlands)|July 19, 2005
Randomized study of vinorelbine--gemcitabine versus vinorelbine--carboplatin in patients with advanced non-small cell lung cancerE H Tan, A Szczesna, M Krzakowski, et al.
Lung Cancer (Amsterdam, Netherlands)|March 1, 2003
Ifosfamide, carboplatin and etoposide combined with 41.8 degrees C whole body hyperthermia for malignant pleural mesotheliomaA Bakhshandeh, I Bruns, A Traynor, et al.
Pageof 8